Back to search results

Dyadic Yoga for Lung or Esophageal Cancer Patients and Caregivers

This study is testing if a dyadic yoga program can improve physical performance and quality of life for patients with stage I-IV non-small cell lung cancer or esophageal cancer who are receiving radiation therapy, and for their caregivers. Dyadic yoga means both the patient and their caregiver participate together. Researchers will compare the yoga program to an education program. They will measure physical performance using a 6-minute walk test three months after the study. This study aims to enroll 400 participants aged 18 and older who can read and speak English. The current status of this study is unclear.

Study design
This interventional study plans to enroll 400 participants, assigning them to either a dyadic yoga program or an education program.
What's involved
Participants will undergo either a dyadic yoga program or a dyadic education program. They will also complete quality-of-life assessments and questionnaires.
Compensation
Not stated in the trial record.
Follow-up
Patient physical performance will be measured at 3 months post study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT03948100

Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers

Recruiting
NAAges 18+InterventionalSupportive care
M.D. Anderson Cancer Center
~400 participants
Updated 2026-04-15 on ClinicalTrials.gov
What's tested:Educational InterventionQuality-of-Life AssessmentQuestionnaire AdministrationYoga

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Patient 6-minute walk test (6MWT)
Measured over At 3 months post study

Conditions

Esophageal Carcinoma
Lung Non-Small Cell Carcinoma
Stage I Lung Cancer AJCC v8
Stage IA1 Lung Cancer AJCC v8
Stage IA2 Lung Cancer AJCC v8
Stage IA3 Lung Cancer AJCC v8
Stage IB Lung Cancer AJCC v8
Stage II Lung Cancer AJCC v8
Stage IIA Lung Cancer AJCC v8
Stage IIB Lung Cancer AJCC v8
Stage III Lung Cancer AJCC v8
Stage IIIA Lung Cancer AJCC v8
Stage IIIB Lung Cancer AJCC v8
Stage IIIC Lung Cancer AJCC v8
Stage IV Lung Cancer AJCC v8
Stage IVA Lung Cancer AJCC v8
Stage IVB Lung Cancer AJCC v8

Explore related trials

Esophageal CarcinomaLung Non-Small Cell Carcinoma

Where it's being run

1 sites across 1 states
Texas1

Study leadership

  • Kathrin Milbury · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center

Who to contact

Kathrin Milbury
[email protected]
713-745-2868
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

PATIENT ONLY: Diagnosed with stage I-IV non-small cell lung cancer (NSCLC) or esophageal cancer and going to receive at least 3 weeks of thoracic radiotherapy (RT)
PATIENT ONLY: Eastern Cooperative Oncology Group (ECOG) performance status of ≤ 2
PATIENT ONLY: Able to read, write and speak English
PATIENT ONLY: Able to provide informed consent
PATIENT ONLY: Having a family caregiver (e.g., spouse, sibling, adult child) who assists the patient during the cancer treatment (e.g., emotional support, transportation, meal preparation, care coordination, etc) per patient self-report. Note, patients must identify a family caregiver; however, the participation of the family caregiver is optional. For caregivers to be eligible, they must be at least 18 years old; able to read, write and speak English; and able to provide informed consent. Family caregivers may consent to participate in the intervention and caregiver assessments or only the assessments based on their preference.

Exclusion

PATIENT ONLY: Who have regularly (self-defined) participated in a mind-body practice in the year prior to diagnosis
PATIENT ONLY: Patients who metastatic disease involving the central nervous system

What this trial measures

  • Patient 6-minute walk test (6MWT)At 3 months post study

    Descriptive statistics for study variables and potential covariates will be computed and distribution characteristics of the variables will be examined. The difference between dyadic yoga (DY) and dyadic edication (DE) at 3 month follow-up (3MFU) will be tested at a two-sided .05 significance level.